3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
2
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Rectal Neoplasms
1
Polyps
1
Neoplastic Syndromes, Hereditary
1
Neoplasms, Germ Cell and Embryonal
1
Medulloblastoma
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Hepatoblastoma
1
Genetic Diseases, Inborn
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Barrett Esophagus
1
Adenomatous Polyps
1
Adenomatous Polyposis Coli
1
Adenoma
1
Interventions
Colonoscopy
3
Cholecalciferol
2
Aspirin
2
alpha-Tocopherol
1
Vitamin E
1
Ursodeoxycholic Acid
1
Selenium
1
Restraint, Physical
1
Polymerase Chain Reaction
1
Narrow Band Imaging
1
Metformin
1
Mass Spectrometry
1
Gene Expression Profiling
1
Folic Acid
1
Erlotinib Hydrochloride
1
Endoscopy
1
Eicosapentaenoic Acid
1
Eflornithine
1
Contraceptive Devices, Female
1
Clinical Chemistry Tests
1
Chromatography, Liquid
1
Chromatography, Gas
1
Celecoxib
1
Calcium Carbonate
1
Calcium
1
Amplified Fragment Length Polymorphism Analysis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Adenomatous Polyps
×
Ursodeoxycholic Acid
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled